Skip to main content
SpringerLink
Log in

Eyelid and Conjunctival Neoplasms

  • Chapter
  • First Online:
Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery

  • 1304 Accesses

Abstract

There are numerous neoplastic lesions that can affect the eyelids and conjunctiva. These most commonly arise from the epithelial layer, but can also arise from any cell type, including connective tissue and lymphoid tissue. Some neoplastic lesions primarily affect the bulbar conjunctiva, some primarily affect the eyelid skin or palpebral conjunctiva, and some neoplastic lesions involve all these structures to various extents. In the following chapter, we will discuss the more common malignant lesions of the eyelid and conjunctiva, covering epidemiology, clinical and pathologic features, and treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am J Dermatopathol. 2009;31(3):256–62. https://doi.org/10.1097/DAD.1090b1013e3181961861.

    Article  PubMed  Google Scholar 

  2. Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746–50.

    PubMed  Google Scholar 

  3. Bielsa I, Soria X, Esteve M, Ferrandiz C. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. Br J Dermatol. 2009;161(6):1341–6.

    CAS  PubMed  Google Scholar 

  4. Dallas RE, Anne K, Peter JH, Peter LR, Michael GW, Bruce KA. Incidence of non-melanocytic skin cancer in Geraldton, Western Australia. Int J Cancer. 1997;73(5):629–33.

    Google Scholar 

  5. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part I: periocular basal cell carcinoma experience over 7 years. Ophthalmology. 2004;111(4):624–30.

    PubMed  Google Scholar 

  6. Nemet AY, Deckel Y, Martin PA, Kourt G, Chilov M, Sharma V, et al. Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol. 2006;142(2):293–7.

    PubMed  Google Scholar 

  7. Zanetti R, Rosso S, Martinez C, Navarro C, Schraub S, Sancho-Garnier H, et al. The multicentre south European Study ‘Helios’. I: skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73(11):1440–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Honavar SG, Shields JA, Shields CL, Eagle RC Jr, Demirci H, Mahmood EZ. Basal cell carcinoma of the eyelid associated with Gorlin-Goltz syndrome. Ophthalmology. 2001;108(6):1115–23.

    CAS  PubMed  Google Scholar 

  9. Malhotra AK, Somesh G, Binod KK, Kaushal KV. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imiquimod 5% cream. Pediatr Dermatol. 2008;25(4):488–91.

    PubMed  Google Scholar 

  10. Batra RS, Larisa CK. A risk scale for predicting extensive subclinical spread of nonmelanoma skin cancer. Dermatol Surg. 2002;28(2):107–12.

    PubMed  Google Scholar 

  11. Auw-Haedrich C, Frick S, Boehringer D, Mittelviefhaus H. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate. Ophthalmology. 2009;116(4):802–6.

    PubMed  Google Scholar 

  12. Smeets NWJ, Kuijpers DIM, Nelemans P, Ostertag JU, Verhaegh MEJM, Krekels GAM, et al. Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face–results of a retrospective study and review of the literature. Br J Dermatol. 2004;151(1):141–7.

    CAS  PubMed  Google Scholar 

  13. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol. 2005;53(3):458–63.

    PubMed  Google Scholar 

  14. Wong VA, Marshall JA, Whitehead KJ, Williamson RM, Sullivan TJ. Management of periocular basal cell carcinoma with modified En face frozen section controlled excision. Ophthal Plast Reconstr Surg. 2002;18(6):430–5.

    PubMed  Google Scholar 

  15. Ramzi SC. Metastasizing basal cell carcinomas. Cancer. 1961;14(5):1036–40.

    Google Scholar 

  16. von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10(6):1043–60.

    Google Scholar 

  17. Robert CGM II, Michael JE, Thomas GC, Catherine LS, Kelly MM. Basosquamous carcinoma. Cancer. 2000;88(6):1365–9.

    Google Scholar 

  18. Evan RF, Elson BH. Metastatic basal cell carcinoma: a clinicopathologic study of seventeen cases. Cancer. 1980;46(4):748–57.

    Google Scholar 

  19. McCord MW, Mendenhall WM, Parsons JT, Amdur RJ, Stringer SP, Cassisi NJ, et al. Skin cancer of the head and neck with clinical perineural invasion. Int J Radiat Oncol Biol Phys. 2000;47(1):89–93.

    CAS  PubMed  Google Scholar 

  20. Leibovitch I, McNab A, Sullivan T, Davis G, Selva D. Orbital invasion by periocular basal cell carcinoma. Ophthalmology. 2005;112(4):717–23.

    PubMed  Google Scholar 

  21. Conway RM, Themel S, Holbach LM. Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years. Br J Ophthalmol. 2004;88(2):236–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Erika LS, Robert JA, William MM, Christopher GM, Jessica MK, Franklin F. Radiotherapy for basal cell carcinoma of the medial canthus region. Laryngoscope. 2009;119(12):2366–8.

    Google Scholar 

  23. Rhodes LE, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Goulden V, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. 2007;143(9):1131–6.

    CAS  PubMed  Google Scholar 

  24. Ll J, Kai K, Hannu U, Matti K. Imiquimod in the treatment of eyelid basal cell carcinoma. Acta Ophthalmol Scand. 2007;85(5):566–8.

    Google Scholar 

  25. Demirci H, Worden F, Nelson CC, Elner VM, Kahana A. Efficacy of Vismodegib (Erivedge) for basal cell carcinoma involving the orbit and periocular area. Ophthal Plast Reconstr Surg. 2015;31(6):463–6.

    PubMed  PubMed Central  Google Scholar 

  26. Gills HS, Moscato EE, Chang AL, Soon S, Silkiss RZ. Vismodegib for periocular and orbital basal cell carcinoma. JAMA Ophthalmol. 2013;131(12):1591–4.

    Google Scholar 

  27. Kahana A, Worden FP, Elner VM. Vismodegib as eye-sparing adjuvant treatment for orbital basal cell carcinoma. JAMA Ophthalmol. 2013;131(10):1364–6.

    PubMed  PubMed Central  Google Scholar 

  28. Yin VT, Pfeiffer ML, Esmaeli B. Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma. Ophthal Plast Reconstr Surg. 2013;29(2):87–92.

    PubMed  Google Scholar 

  29. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog pathway in patients with basal-cell nevus syndrome. N Engl J Med. 2012;366(23):2180–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Gallagher RP, Hill GB, Bajdik CD, Coldman AJ, Fincham S, McLean DI, et al. Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. Arch Dermatol. 1995;131(2):164–9.

    CAS  PubMed  Google Scholar 

  31. Maurice EA, Ogbu N, Godwin E, Ekpo EB. Skin cancers amongst four Nigerian albinos. Int J Dermatol. 2009;48(6):636–8.

    Google Scholar 

  32. Herman S, Rogers HD, Ratner D. Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant. Skinmed. 2007;6(5):234–8.

    PubMed  Google Scholar 

  33. Perry JD, Polito SC, Chundury RV, et al. Periocular skin cancer in solid organ transplant recipients. Ophthalmology. 2016;123(1):203–8.

    PubMed  Google Scholar 

  34. Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(Suppl3):8–12.

    PubMed  Google Scholar 

  35. Cassarino DS, Derienzo DP, Barr RJ. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification–part two. J Cutan Pathol. 2006;33(4):261–79.

    PubMed  Google Scholar 

  36. Lohmann CM, Solomon AR. Clinicopathologic variants of cutaneous squamous cell carcinoma. Adv Anat Pathol. 2001;8(1):27–36.

    CAS  PubMed  Google Scholar 

  37. Faustina M, Diba R, Ahmadi MA, Esmaeli B. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology. 2004;111(10):1930–2.

    PubMed  Google Scholar 

  38. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.

    CAS  PubMed  Google Scholar 

  39. Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology. 2004;111(4):617–23.

    PubMed  Google Scholar 

  40. Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86(10):1161–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Bowyer JD, Sullivan TJ, Whitehead KJ, Kelly LE, Allison RW. The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstr Surg. 2003;19(4):275–81.

    PubMed  Google Scholar 

  42. Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2099–100.

    Google Scholar 

  43. Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KSC, et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer. 2008;112(1):111–8.

    PubMed  Google Scholar 

  44. Russell WH, Daniel JI, Robert JA, Christopher GM, John WW, Mikhail V, et al. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope. 2008;118(11):1989–96.

    Google Scholar 

  45. Phan R, Phan L, Ginsberg LE, Blumenschein G, Williams MD, Esmaeli B. Durable response to chemotherapy for recurrent squamous cell carcinoma of the cheek with perineural spread. Arch Ophthalmol. 2009;127(8):1074–5.

    PubMed  Google Scholar 

  46. Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, et al. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998;16(4):1325–30.

    CAS  PubMed  Google Scholar 

  47. Rahman I, Maino A, Cook AE, Leatherbarrow B. Mortality following exenteration for malignant tumours of the orbit. Br J Ophthalmol. 2005;89(11):1445–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Fitzpatrick PJ, Thompson GA, Easterbrook WM, Gallie BL, Payne DG. Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys. 1984;10(4):449–54.

    CAS  PubMed  Google Scholar 

  49. Calista D, Riccioni L, Coccia L. Successful treatment of squamous cell carcinoma of the lower eyelid with intralesional cidofovir. Br J Ophthalmol. 2002;86(8):932–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Calzavara-Pinton PG, Venturini M, Sala R, Capezzera R, Parrinello G, Specchia C, et al. Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. Br J Dermatol. 2008;159(1):137–44.

    CAS  PubMed  Google Scholar 

  51. Yin VT, Merritt H, Esmaeli B. Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas. World J Clin Cases. 2014;16(9):432–8.

    Google Scholar 

  52. Migden MR, Rischin D, Schmults CD, et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018;379:341–51.

    CAS  PubMed  Google Scholar 

  53. David BR, Elson BH. Cutaneous sebaceous neoplasms. Cancer. 1974;33(1):82–102.

    Google Scholar 

  54. Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982;13(2):113–22.

    CAS  PubMed  Google Scholar 

  55. Song A, Carter KD, Syed NA, Song J, Nerad JA. Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes. Ophthal Plast Reconstr Surg. 2008;24(3):194–200.

    PubMed  Google Scholar 

  56. Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111(12):2151–7.

    PubMed  Google Scholar 

  57. Boniuk M, Zimmermann LE. Sebaceous carcinoma of the eyelid, eyebrow, caruncle and orbit. Int Ophthalmol Clin. 1972;12(1):225–57.

    CAS  PubMed  Google Scholar 

  58. Takamura H, Yamashita H. Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol. 2005;49(5):349–54.

    PubMed  Google Scholar 

  59. Tina D, Lynn DW, James BY. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer. 2009;115(1):158–65.

    Google Scholar 

  60. Muqit MM, Roberts F, Lee WR, Kemp E. Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond). 2004;18(1):49–53.

    CAS  Google Scholar 

  61. Richard PH, William JL, William HS, Edward GB, Jonathan JD, Gordon KK, et al. Sebaceous gland carcinoma: a subtle second malignancy following radiation therapy in patients with bilateral retinoblastoma. Cancer. 1998;83(4):767–71.

    Google Scholar 

  62. Rumelt S, Hogan NR, Rubin PA, Jakobiec FA. Four-eyelid sebaceous cell carcinoma following irradiation. Arch Ophthalmol. 1998;116(12):1670–2.

    CAS  PubMed  Google Scholar 

  63. Rishi K, Font RL. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review. Ophthal Plast Reconstr Surg. 2004;20(1):31–6.

    PubMed  Google Scholar 

  64. Tan KC, Lee ST, Cheah ST. Surgical treatment of sebaceous carcinoma of eyelids with clinico-pathological correlation. Br J Plast Surg. 1991;44(2):117–21.

    CAS  PubMed  Google Scholar 

  65. Doxanas MT, Green WR. Sebaceous gland carcinoma: review of 40 cases. Arch Ophthalmol. 1984;102(2):245–9.

    CAS  PubMed  Google Scholar 

  66. Miki I, Kiyoshi M, Takeshi N, Jun M, Keiichi I, Cheng-Sheng C, et al. Sebaceous carcinoma of the eyelids: thirty cases from Japan. Pathol Int. 2008;58(8):483–8.

    Google Scholar 

  67. Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology. 2012;119(5):1078–82.

    PubMed  Google Scholar 

  68. Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg. 2007;133(8):820–6.

    PubMed  Google Scholar 

  69. Husain A, Blumenschein G, Esmaeli B. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid. Int J Dermatol. 2008;47(3):276–9.

    PubMed  Google Scholar 

  70. Chao AN, Shields CL, Krema H, Shields JA. Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology. 2001;108(10):1877–83.

    CAS  PubMed  Google Scholar 

  71. Spencer JM, Nossa R, Tse DT, Sequeira M. Sebaceous carcinoma of the eyelid treated with Mohs micrographic surgery. J Am Acad Dermatol. 2001;44(6):1004–9.

    CAS  PubMed  Google Scholar 

  72. Folberg R, Whitaker DC, Tse DT, Nerad JA. Recurrent and residual sebaceous carcinoma after Mohs’ excision of the primary lesion. Am J Ophthalmol. 1987;103(6):817–23.

    CAS  PubMed  Google Scholar 

  73. Shields JA, Demirci H, Marr BP, Eagle RC Jr, Stefanyszyn M, Shields CL. Conjunctival epithelial involvement by eyelid sebaceous carcinoma. The 2003 J. Howard stokes lecture. Ophthal Plast Reconstr Surg. 2005;21(2):92–6.

    PubMed  Google Scholar 

  74. Adam KR, James SM. Mitomycin-C as adjuvant therapy in the treatment of sebaceous gland carcinoma in high-risk locations. Clin Exp Ophthalmol. 2009;37(4):352–6.

    Google Scholar 

  75. Yen MT, Tse DT, Wu X, Wolfson AH. Radiation therapy for local control of eyelid sebaceous cell carcinoma: report of two cases and review of the literature. Ophthal Plast Reconstr Surg. 2000;16(3):211–5.

    CAS  PubMed  Google Scholar 

  76. Hoersch B, Leiter U, Garbe C. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma. Br J Dermatol. 2006;155(4):771–7.

    CAS  PubMed  Google Scholar 

  77. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds). Seer cancer statistics review. Bethesda, 2010. http://seer.cancer.gov/csr/1975_2006/. Accessed 25 Feb 2010 based on November 2008 SEER data submission, posted to the SEER web site (2009).

  78. Flaherty KT, Robert C, Hersey P, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367(2):107–14.

    CAS  PubMed  Google Scholar 

  79. Atkins M. Immunotherapy combinations with checkpoint inhibitors in metastatic melanoma: current approaches and future directions. Semin Oncol. 2015;42(Suppl 3):s12–9.

    CAS  PubMed  Google Scholar 

  80. Marrett LD, King WD, Walter SD, From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma. CMAJ. 1992;147(4):445–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol. 2003;120(6):1087–93.

    CAS  PubMed  Google Scholar 

  82. Yu GP, Hu DM, McCormick SA. Latitude and incidence of ocular melanoma. Photochem Photobiol. 2006;82(6):1621–6.

    CAS  PubMed  Google Scholar 

  83. Tsai T, Vu C, Henson DE. Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res. 2005;15(3):213–7.

    PubMed  Google Scholar 

  84. Newnham A, Moller H. Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960–1998. J Public Health. 2002;24(4):268–75.

    CAS  Google Scholar 

  85. William T, Kara S, Natalie NC, Michael P, Hobart WW. Tanning Bed exposure increases the risk of malignant melanoma. Int J Dermatol. 2007;46(12):1253–7.

    Google Scholar 

  86. Wang Y, Digiovanna JJ, Stern JB, Hornyak TJ, Raffeld M, Khan SG, et al. Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. Proc Natl Acad Sci U S A. 2009;106(15):6279–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Margo CE, Duncan WC, Rich A, Garcia E, Stricker J. Periocular cutaneous melanoma arising in a radiotherapy field. Ophthal Plast Reconstr Surg. 2004;20(4):319–20.

    PubMed  Google Scholar 

  88. Fortes C, Mastroeni S, Melchi F, Pilla MA, Alotto M, Antonelli G, et al. The association between residential pesticide use and cutaneous melanoma. Eur J Cancer. 2007;43(6):1066–75.

    CAS  PubMed  Google Scholar 

  89. Sanchez R, Ivan D, Esmaeli B. Eyelid and periorbital cutaneous malignant melanoma. Int Ophthalmol Clin. 2009;49(4):25–43.

    PubMed  Google Scholar 

  90. Esmaeli B, Wang B, Deavers M, Gillenwater A, Goepfert H, Diaz E, et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg. 2000;16(4):250–7.

    CAS  PubMed  Google Scholar 

  91. Golger A, Young DS, Ghazarian D, Neligan PC. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study. Arch Otolaryngol Head Neck Surg. 2007;133(5):442–7.

    PubMed  Google Scholar 

  92. Nagore E, Oliver V, Botella-Estrada R, Moreno-Picot S, Insa A, Fortea JM. Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis. Melanoma Res. 2005;15(3):169–77.

    PubMed  Google Scholar 

  93. Savar A, Ross MI, Prieto VG, Ivan D, Kim S, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology. 2009;116(11):2217–23.

    PubMed  Google Scholar 

  94. Chan FM, O’Donnel BA, Whitehead K, Ryman W, Sullivan TJ. Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia. Ophthalmology. 2007;114(1):187–92.

    PubMed  Google Scholar 

  95. Michael MW, Arthur JS, Thomas BF, Martin CM, Alfred WK, Wallace HC, et al. Clinical characteristics of early cutaneous melanoma. Cancer. 1980;45(10):2684–6.

    Google Scholar 

  96. Kittler H, Seltenheim M, Dawid M, Pehamberger H, Wolff K, Binder M. Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy. J Am Acad Dermatol. 1999;40(4):558–62.

    CAS  PubMed  Google Scholar 

  97. Vaziri M, Buffam FV, Martinka M, Oryschak A, Dhaliwal H, White VA. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology. 2002;109(5):901–8.

    PubMed  Google Scholar 

  98. Lessner A, Sexton M, Margo CE. Amelanotic malignant melanoma of the eyelid. Arch Ophthalmol. 1991;109(8):1166–7.

    CAS  PubMed  Google Scholar 

  99. Gualandri L, Betti R, Crosti C. Clinical features of 36 cases of amelanotic melanomas and considerations about the relationship between histologic subtypes and diagnostic delay. J Eur Acad Dermatol Venereol. 2009;23(3):283–7.

    CAS  PubMed  Google Scholar 

  100. Gündüz K, Shields JA, Shields CL, Eagle RC Jr. Periorbital cellular blue nevus leading to orbitopalpebral and intracranial melanoma. Ophthalmology. 1998;105(11):2046–50.

    PubMed  Google Scholar 

  101. Patel BC, Egan CA, Lucius RW, Gerwels JW, Mamalis N, Anderson RL. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature. J Am Acad Dermatol. 1998;38(5 Pt 2):862–5.

    CAS  PubMed  Google Scholar 

  102. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC, et al. Guidelines/outcomes committee: guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 2001;45(4):579–86.

    CAS  PubMed  Google Scholar 

  103. Esmaeli B, Youssef A, Naderi A, Ahmadi MA, Meyer DR, McNab A. Margins of excision for cutaneous melanoma of the eyelid skin: the collaborative eyelid skin melanoma group report. Ophthal Plast Reconstr Surg. 2003;19(2):96–101.

    PubMed  Google Scholar 

  104. Then SY, Malhotra R, Barlow R, Kurwa H, Huilgol S, Joshi N, et al. Early cure rates with narrow-margin slow-mohs surgery for periocular malignant melanoma. Dermatol Surg. 2009;35(1):17–23.

    CAS  PubMed  Google Scholar 

  105. Prieto VG, Argenyi ZB, Barnhill RL, Duray PH, Elenitsas R, From L, et al. Are En face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol. 2003;120(2):203–8.

    PubMed  Google Scholar 

  106. Shumaker PR, Kelley B, Swann MH, Greenway HT. Modified Mohs micrographic surgery for periocular melanoma and melanoma in situ: long-term experience at Scripps clinic. Dermatol Surg. 2009;35(8):1263–70.

    CAS  PubMed  Google Scholar 

  107. Menaker GM, Chiang JK, Tabila B, Moy RL. Rapid Hmb-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma. J Am Acad Dermatol. 2001;44(5):833–6.

    CAS  PubMed  Google Scholar 

  108. Stannard CE, Sealy GR, Hering ER, Pereira SB, Knowles R, Hill JC. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology. 2000;107(5):951–8.

    CAS  PubMed  Google Scholar 

  109. Masayuki S, Kohji T, Hidehiko Y, Airo T, Yasuaki N, Kazuo N. Apocrine adenocarcinoma of the eyelid with aggressive biological behavior: report of a case. Pathol Int. 2002;52(2):169–73.

    Google Scholar 

  110. Hoppenreijs VPT, Reuser TTQ, Mooy CM, de Keizer RJW, Mourits MP. Syringomatous carcinoma of the eyelid and orbit: a clinical and histopathological challenge. Br J Ophthalmol. 1997;81(8):668–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  111. John DW, Ramon LF. Mucinous sweat gland adenocarcinoma of eyelid. A clinicopathologic study of 21 cases with histochemical and electron microscopic observations. Cancer. 1979;44(5):1757–68.

    Google Scholar 

  112. Duffy MT, Harrison W, Sassoon J, Hornblass A. Sclerosing sweat duct carcinoma of the eyelid margin: unusual presentation of a rare tumor. Ophthalmology. 1999;106(4):751–6.

    CAS  PubMed  Google Scholar 

  113. Durairaj VD, Hink EM, Kahook MY, Hawes MJ, Paniker PU, Esmaeli B. Mucinous eccrine adenocarcinoma of the periocular region. Ophthal Plast Reconstr Surg. 2006;22(1):30–5.

    PubMed  Google Scholar 

  114. Wollensak G, Witschel H, Böhm N. Signet ring cell carcinoma of the eccrine sweat glands in the eyelid. Ophthalmology. 1996;103(11):1788–93.

    CAS  PubMed  Google Scholar 

  115. Baker MS, Yin VT, Ivan D, Allen RC, Carter KD, Esmaeli B, Shriver EM. Epidemiology and prognosis of primary periocular sweat gland carcinomas. Ophthalmic Plast Reconstr Surg. 2017;33(2):101–5.

    PubMed  Google Scholar 

  116. Auw-Haedrich C, Boehm N, Weissenberger C. Signet ring carcinoma of the eccrine sweat gland in the eyelid, treated by radiotherapy alone. Br J Ophthalmol. 2001;85(1):112–3.

    CAS  PubMed  Google Scholar 

  117. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003;49(5):832–41.

    PubMed  Google Scholar 

  118. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomark Prev. 1999;8(2):153–8.

    CAS  Google Scholar 

  119. Buell JF, Trofe J, Hanaway MJ, Beebe TM, Gross TG, Alloway RR, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780–1.

    CAS  PubMed  Google Scholar 

  120. Rawlings NG, Brownstein S, Jordan DR. Merkel cell carcinoma masquerading as chalazion. Can J Ophthalmol. 2007;24(3):469–70.

    Google Scholar 

  121. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histopathologic features and prognosis. Cancer. 2008;113(9):2549–58.

    PubMed  Google Scholar 

  122. Gillenwater AM, Hessel AC, Morrison WH, Burgess MA, Silva EG, Roberts D, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127(2):149–54.

    CAS  PubMed  Google Scholar 

  123. Jonathan RC, Michael JV, Ralph G, Christopher JOB, Patrick JG. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck. 2007;29(3):249–57.

    Google Scholar 

  124. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8(3):204–8.

    CAS  PubMed  Google Scholar 

  125. Eich HT, Eich D, Staar S, Mauch C, Stützer H, Groth W, et al. Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol. 2002;25(1):50–6.

    PubMed  Google Scholar 

  126. Michael JV, Gary JM, Val G. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck. 2005;27(3):208–16.

    Google Scholar 

  127. Esmaeli B, Naderi A, Hidaji L, Blumenschein G, Prieto VG. Merkel cell carcinoma of the eyelid with a positive sentinel node. Arch Ophthalmol. 2002;120(5):646–8.

    PubMed  Google Scholar 

  128. Luir MT, Rufus M, Robert M, Thomas CC, Robert GP. Sarcomas of the head and neck. Prognostic factors and treatment strategies. Cancer. 1992;70(1):169–77.

    Google Scholar 

  129. William HM, Robert MB, Adam SG, Harry LE, Ang KK, Lester JP. Cutaneous angiosarcoma of the head and neck. A therapeutic dilemma. Cancer. 1995;76(2):319–27.

    Google Scholar 

  130. Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28(6):781–8.

    PubMed  Google Scholar 

  131. Mauricio G-Y. Cutaneous angiosarcoma arising on the radiation site of a congenital facial hemangioma. Int J Dermatol. 1998;37(8):638–9.

    Google Scholar 

  132. Lapidus CS, Sutula FC, Stadecker MJ, Vine JE, Grande DJ. Angiosarcoma of the eyelid: yellow plaques causing ptosis. J Am Acad Dermatol. 1996;34(2 Pt 1):308–10.

    CAS  PubMed  Google Scholar 

  133. Ettl T, Kleinheinz J, Mehrotra R, Schwarz S, Reichert T, Driemel O. Infraorbital cutaneous angiosarcoma: a diagnostic and therapeutic dilemma. Head Face Med. 2008;4(1):18.

    PubMed  PubMed Central  Google Scholar 

  134. Rosai J, Sumner HW, Kostianovsky M, Perez-Mesa C. Angiosarcoma of the skin. A clinicopathologic and fine structural study. Hum Pathol. 1976;7(1):83–109.

    CAS  PubMed  Google Scholar 

  135. DeMartelaere SL, Roberts D, Burgess MA, Morrison WH, Pisters PW, Sturgis EM, et al. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck. 2008;30(5):639–46.

    PubMed  Google Scholar 

  136. Reiser BJ, Mok A, Kukes G, Kim JW. Non-AIDS-related Kaposi sarcoma involving the tarsal conjunctiva and eyelid margin. Arch Ophthalmol. 2007;125(6):838–40.

    PubMed  Google Scholar 

  137. Qureshi YA, Karp CL, Dubovy SR. Intralesional interferon alpha-2b therapy for adnexal Kaposi sarcoma. Cornea. 2009;28(8):941–3. https://doi.org/10.1097/ICO.1090b1013e3181967338.

    Article  PubMed  Google Scholar 

  138. Kirova YM, Belembaogo E, Frikha H, Haddad E, Calitchi E, Levy E, et al. Radiotherapy in the management of epidemic Kaposi’s sarcoma: a retrospective study of 643 cases. Radiother Oncol. 1998;46(1):19–22.

    CAS  PubMed  Google Scholar 

  139. Vivek BP, Conway RM, Simon FT. Primary cutaneous B cell lymphoma presenting as recurrent eyelid swelling. Clin Exp Ophthalmol. 2008;36(7):672–4.

    Google Scholar 

  140. Justin AG, Rodger D. Mycosis fungoides causing severe lower eyelid ulceration. Clin Exp Ophthalmol. 2002;30(5):369–71.

    Google Scholar 

  141. Lker GL, SeÁil S, Erkan A, Zeliha Y, Murat DRZ. Uncommon presentation of mycosis fungoides: eyelid margin involvement. J Dermatol. 2008;35(9):581–4.

    Google Scholar 

  142. Fonseca NL Jr, Lucci LMD, Cha SB, Rossetti C, Rehder JRCL. Metastatic eyelid disease associated with primary breast carcinoma: case report. Arq Bras Oftalmol. 2009;72:390–3.

    PubMed  Google Scholar 

  143. Douglas RS, Goldstein SM, Einhorn E, Ibarra MS, Gausas RE. Metastatic breast cancer to 4 eyelids: a clinicopathologic report. Cutis. 2002;70(5):291–5.

    PubMed  Google Scholar 

  144. Yeung SN, Blicker JA, Buffam FV, Chung SW, White VA. Metastatic eyelid disease associated with hepatocellular carcinoma. Can J Ophthalmol. 2007;42(5):752–4.

    PubMed  Google Scholar 

  145. Bianciotto C, Demirci H, Shields CL, Eagle RC Jr, Shields JA. Metastatic tumors to the eyelid: report of 20 cases and review of the literature. Arch Ophthalmol. 2009;127(8):999–1005.

    PubMed  Google Scholar 

  146. Esmaeli B, Cleary KL, Ho L, Safar S, Prieto VG. Leiomyosarcoma of the esophagus metastatic to the eyelid: a clinicopathologic report. Ophthal Plast Reconstr Surg. 2002;18(2):159–61.

    PubMed  Google Scholar 

  147. McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the US. Cancer. 2005;103(5):1000–7.

    PubMed  Google Scholar 

  148. Shields CL, Shields JA, Gunduz K, Cater J, Mercado GV, Gross N, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol. 2000;118(11):1497–507.

    CAS  PubMed  Google Scholar 

  149. Ackerman AB, Sood R, Koenig M. Primary acquired melanosis of the conjunctiva is melanoma in situ. Mod Pathol. 1991;4(2):253–63.

    CAS  PubMed  Google Scholar 

  150. Folberg R, Jakobiec FA, McLean IW, Zimmerman LE. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ? Mod Pathol. 1992;5(1):2–5. discussion 6–8.

    CAS  PubMed  Google Scholar 

  151. Shields JA, Shields CL, Mashayekhi A, Marr BP, Benavides R, Thangappan A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Trans Am Ophthalmol Soc. 2007;105:61–71. discussion 71–62.

    PubMed  PubMed Central  Google Scholar 

  152. Jakobiec FA, Bhat P, Colby KA. Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol. 2010;128(2):174–83.

    PubMed  Google Scholar 

  153. Tuomaala S, Eskelin S, Tarkkanen A, Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest Ophthalmol Vis Sci. 2002;43(11):3399–408.

    PubMed  Google Scholar 

  154. Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA. The prognostic significance of ulceration of cutaneous melanoma. Cancer. 1980;45(12):3012–7.

    CAS  PubMed  Google Scholar 

  155. Savar A, Esmaeli B, Ho H, Liu S, Prieto VG. Conjunctival melanoma: localregional control rates, and impact of high-risk histologic features. J Cutan Patho. 2011;38(1):18–24.

    Google Scholar 

  156. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol. 1996;234(9):569–72.

    CAS  PubMed  Google Scholar 

  157. Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years’ experience. Graefes Arch Clin Exp Ophthalmol. 2005;243(11):1108–14.

    CAS  PubMed  Google Scholar 

  158. Hsu A, Frank SJ, Ballo MT, Garden AS, Morrison WH, Rosenthal DI, et al. Post-operative adjuvant external-beam radiation therapy for cancers of the eyelid and conjunctiva. Ophthal Plast Reconstr Surg. 2008;24(6):444–9.

    PubMed  Google Scholar 

  159. Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, Arslan A, Othieno E, Binta-Kahwa J, et al. Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. Br J Cancer. 2010;102(2):262–7.

    CAS  PubMed  Google Scholar 

  160. Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM. Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer. 2008;122(11):2590–3.

    CAS  PubMed  Google Scholar 

  161. Porges Y, Groisman GM. Prevalence of HIV with conjunctival squamous cell neoplasia in an African provincial hospital. Cornea. 2003;22(1):1–4.

    PubMed  Google Scholar 

  162. Cervantes G, Rodriguez AA Jr, Leal AG. Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases. Can J Ophthalmol. 2002;37(1):14–9. discussion 19–20.

    PubMed  Google Scholar 

  163. Mauriello JA Jr, Abdelsalam A, McLean IW. Adenoid squamous carcinoma of the conjunctiva-a clinicopathological study of 14 cases. Br J Ophthalmol. 1997;81(11):1001–5.

    PubMed  PubMed Central  Google Scholar 

  164. Heindl LM, Hofmann-Rummelt C, Adler W, Holbach LM, Naumann GO, Kruse FE, et al. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology. 2010;117(4):649–58.

    PubMed  Google Scholar 

  165. Cha SB, Shields JA, Shields CL, Wang MX. Squamous cell carcinoma of the conjunctiva. Int Ophthalmol Clin. 1993;33(3):19–24.

    CAS  PubMed  Google Scholar 

  166. Midena E, Angeli CD, Valenti M, de Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol. 2000;84(3):268–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  167. Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin Ophthalmol. 2008;2(3):503–15.

    CAS  PubMed  PubMed Central  Google Scholar 

  168. Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon alpha2b for ocular surface squamous neoplasia a 10-year review. Ophthalmology. 2010;117(12):2241–6. [epub ahead of print].

    PubMed  Google Scholar 

  169. Shepler TR, Prieto VG, Diba R, Neuhaus RW, Shore JW, Esmaeli B. Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma. Ophthal Plast Reconstr Surg. 2006;22(2):113–5.

    PubMed  Google Scholar 

  170. Shields CL, Shields JA, Honavar SG, Demirci H. Primary ophthalmic rhabdomyosarcoma in 33 patients. Trans Am Ophthalmol Soc. 2001;99:133–42. discussion 142–133

    CAS  PubMed  PubMed Central  Google Scholar 

  171. Kiratli H, Shields CL, Shields JA, DePotter P. Metastatic tumours to the conjunctiva: report of 10 cases. Br J Ophthalmol. 1996;80(1):5–8.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, Department of Ophthalmology, Rochester, MN, USA

    Lilly Wagner

  2. Stein Eye Institute, UCLA, Department of Ophthalmology, Los Angeles, CA, USA

    Aaron Savar

  3. Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, MD Anderson Cancer Center, Houston, TX, USA

    Bita Esmaeli

Authors
  1. Lilly Wagner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aaron Savar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bita Esmaeli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bita Esmaeli .

Editor information

Editors and Affiliations

  1. Oculofacial Plastic Surgeons of Georgia, Suwanee, GA, USA

    J. Javier Servat

  2. Consultants in Ophthalmic and Facial Plastic Surgery, P.C., Southfield, MI, USA

    Evan H. Black

  3. Beaumont Eye Institute, William Beaumont School of Medicine of Oakland University, Rochester, MI, USA

    Frank A. Nesi

  4. Consultants in Ophthalmic and Facial Plastic Surgery, P.C., Southfield, MI, USA

    Geoffrey J. Gladstone

  5. San Antonio Military Medical Center/Wilford Hall Ambulatory Surgery Center, Department of Ophthalmology and Oculoplastic Surgery, San Antonio, TX, USA

    Christopher J. Calvano

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wagner, L., Savar, A., Esmaeli, B. (2021). Eyelid and Conjunctival Neoplasms. In: Servat, J.J., Black, E.H., Nesi, F.A., Gladstone, G.J., Calvano, C.J. (eds) Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-41720-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41720-8_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41719-2

  • Online ISBN: 978-3-030-41720-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation